Workflow
健帆生物: 关于健帆转债暂停转股的提示性公告

Group 1 - The company issued 10 million convertible bonds with a total amount of RMB 1 billion, with a maturity of 6 years from June 23, 2021 [1] - The conversion price for the bonds is set at RMB 38.65 per share, and if the stock price falls below 70% of this price (RMB 27.06) for 30 consecutive trading days, the conditional redemption clause will take effect [1] - The bonds are currently in the conversion period, and the company has announced a conditional redemption due to the stock price situation [1] Group 2 - The company has applied to suspend the conversion of the bonds during the redemption application period, which will start on August 8, 2025, and last for 5 trading days until August 14, 2025 [2] - Normal trading of the bonds will continue during the suspension period, and conversion will resume on August 15, 2025 [2] - Bondholders are advised to pay attention to the announcement regarding the suspension and resumption of conversion [2]